[Federal Register: August 2, 2006 (Volume 71, Number 148)]
[Notices]
[Page 43813]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02au06-110]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated March 20, 2006 and published in the Federal
Register on March 24, 2006, (71 FR 14948), Cerilliant API Services LLC,
811 Paloma Drive, Suite A, Round Rock, Texas 78664, made application to
the Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of controlled substances listed in
Schedule I and II; and by letter to modify its name to Austin Pharma
LLC. Subsequent to the publication of the Notice of Application, by
letter, the company has also requested to withdraw thirty-five drug
codes from their initial application request.
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
Alphamethadol (9605)....................... I
Methadone (9250)........................... II
Methadone intermediate (9254).............. II
Levo-alphacetylmethadol (9648)............. II
Alfentanil (9737).......................... II
Remifentanil (9739)........................ II
Sufentanil (9740).......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
In reference to drug code 7360 (Marihuana), the company plans to
bulk manufacture cannabidiol as a synthetic intermediate. This
controlled substance will be further synthesized to bulk manufacture a
synthetic THC (7370). No other activity for this drug code is
authorized for this registration.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Cerilliant API Services LLC to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Cerilliant API Services LLC to ensure that
the company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: July 26, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-12478 Filed 8-1-06; 8:45 am]
BILLING CODE 4410-09-P